Medical Polyoxymethylene Market Regional Analysis:
APAC Market Insights
The Asia Pacific medical polyoxymethylene (POM) market, amongst the market in all the other regions, is poised to dominate 38% revenue share by 2035, growing at a highest CAGR of 6.7% over the forecast period. The growth of the market in this region can be attributed to upsurge in industrialization, and expanding healthcare sector. Further, growing prevalence of diabetes is also estimated to boost the market growth in this region. For instance, India has about 16% of all diabetes patients worldwide, earning it the moniker "Diabetes Capital of the World." India has close to 70 million diabetics in 2022, and by the year 2045, that figure is projected to rise to about 134 million.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of medical polyoxymethylene is evaluated at USD 169.28 million.
The global medical polyoxymethylene market size was worth over USD 161.57 million in 2025 and is poised to grow at a CAGR of over 5.3%, reaching USD 270.8 million revenue by 2035.
Asia Pacific medical polyoxymethylene (pom) market will secure around 38% share by 2035, fueled by expanding healthcare sector and diabetes prevalence.
Key players in the market include BASF SE, Celanese Corporation, Polyplastics Co. Ltd, DuPont de Nemours Inc, Ensinger, Korea Engineering Plastics Co. Ltd, Mitsubishi Chemical Corporation, Westlake Plastics Company, Asahi Kasei Corporation, PolyOne Corporation.
